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Abstract
Background—Genetic and environmental factors contribute to the risk of depression and several 
studies have noted an association between tobacco smoke and depression. Cadmium is a 
neurotoxicant, and the main source of non-occupational exposure is tobacco smoke.
Methods—We conducted a cross-sectional analysis of data from 2892 young adult (20-39 years) 
participants of the National Health and Nutrition Examination Survey (NHANES) 2007-2010. 
Multivariate logistic regressions – adjusted for age, sex, race/ethnicity, education, poverty-income 
ratio, obesity, alcohol intake, blood lead, and smoking status – were used to analyze the 
association between blood cadmium and depressive symptoms, as determined by score on the 
PHQ-9.
Results—Individuals in the highest quartile of blood cadmium had higher odds of having 
depressive symptoms (OR=2.79; 95% CI, 1.84, 4.25) compared to those in the lowest blood 
cadmium quartile. Smoking status was statistically significantly associated with depressive 
symptoms while blood lead was not. Stratification by smoking status found that blood cadmium 
was significantly associated with depressive symptoms in both non-smokers (OR=2.91; 95% CI, 
1.12, 7.58) and current smokers (OR=2.69; 95% CI, 1.13, 6.42).
Conclusions—This is the first study reporting an association of blood cadmium levels with 
depressive symptoms using a nationally representative sample. The association of cadmium with 
depressive symptoms was independent of smoking status. If this association is further confirmed, 
the continued efforts at reducing cadmium exposures, mainly through tobacco smoking cessation 
programs, may decrease the incidence of depression.
INTRODUCTION
Depression is a common mental disorder and a major cause of illness and disability 
worldwide (Kessler & Bromet 2013). Depression is among the leading causes of decreased 
work productivity (Stewart et al. 2003). The estimated prevalence of depression among U.S. 
adults is currently 9.1% (http://www.cdc.gov/features/dsdepression/index.html#reference). 
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Both genetic and environmental factors contribute to the risk of depression (Lanni et al. 
2009).
Individuals with depression as well as mental illness in general have a higher rate of 
cigarette smoking. However, the association between tobacco smoking and depression 
seems to be bidirectional. On one hand, there is evidence suggesting cigarette smoking 
increases the risk of depression (Aubin et al. 2012; Boden et al. 2010; Weaver & Etzel 2003) 
on the other hand, increased cigarette smoking may be a result of self-medication (Crone & 
Reijneveld 2007; Lerman et al. 1998; Pomerleau & Pomerleau 1992). Tobacco and tobacco 
smoke contain over 8,400 chemical constituents (Rodgman & Perfetti 2008). Among the 
compounds found in tobacco smoke are lead, which has been associated with major 
depression (Bouchard et al. 2009), and cadmium, which has neurotoxic properties (ATSDR 
2012).
Cadmium is a non-essential carcinogenic metal that occurs in the earth’s crust and is 
commonly associated with zinc, lead, and copper ores and is a natural constituent of ocean 
water (ATSDR 2012). Cadmium is released into the atmosphere via natural and 
anthropogenic sources with emissions from anthropogenic sources greatly exceeding those 
of natural origin. Major industrial sources of cadmium emissions include zinc, lead, copper, 
and cadmium smelting operations, coal and oil-fired boiler, phosphate fertilizer manufacture 
– a major source of cadmium input to agricultural soil, and municipal and sewage sludge 
incinerators. Cadmium bioaccumulates at all levels of the food chain, with the highest levels 
found in leafy vegetables, such as lettuce and spinach, potatoes, grains, peanuts, and organ 
meats such as liver and kidney. Additionally, cadmium naturally accumulates in large 
amounts in tobacco leaves. Cadmium-containing products including nickel-cadmium 
batteries, jewelry, toys, and electronic devices are another important source of exposure. 
Among the routes of exposure, inhalation is the predominant route of exposure for the 
smoking general population and for occupational populations, whereas oral exposure is the 
predominant route of exposure for the nonsmoking general population. Dermal exposure 
plays a minor role in exposure for the general population. Cadmium toxicity affects several 
organs including kidney, lung, liver and brain (ATSDR 2012).
Cadmium association with neurobehavioral effect was found in occupational studies (Hart et 
al. 1989; Viaene et al. 2000), as well as in animal studies (Ali et al. 1990; Baranski 1984; 
Goncalves et al. 2012; Leret et al. 2003). Cadmium exposure was associated with learning 
disabilities and lower neuropsychological test scores in children (Capel et al. 1981; 
Ciesielski et al. 2012; Stellern et al. 1983)). A statistically significant increase of serum 
cadmium and lead was also found in patients with depression compared to healthy age- and 
sex-matched controls (Stanley & Wakwe 2002).
Based on this evidence of a possible association between cadmium and neurobehavioral 
outcomes we decided to analyze a large representative sample of U.S. young adults, 20-39 
years of age, from the National Health and Nutrition Examination Survey (NHANES) to 
determine whether blood cadmium is associated with depressive symptoms. To our 
knowledge, this is the first study reporting on the association of blood cadmium levels with 
depressive symptoms using a nationally representative sample.
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METHODS
Study population
NHANES is a cross-sectional, nationally representative survey of the non-institutionalized 
civilian population of the United States conducted by the National Center for Health 
Statistics, CDC (NCHS 2008a). Beginning in 1999, the survey has been conducted 
continuously and released in 2-year cycles. For our study we merged the publicly available 
files for NHANES cycles 2007-2008, and 2009-2010 using the NCHS recommendations 
(NCHS 2008b). The survey employs a multistage stratified probability sample based on 
selected counties, blocks, households, and persons within households.
NCHS-trained professionals conducted interviews in participants’ homes, and extensive 
physical examinations, including blood collection, were conducted at mobile exam centers 
(MECs). CDC’s National Center for Environmental Health (NCEH), Division of Laboratory 
Sciences (DLS) coordinates the National Biomonitoring Program (NBP) which offers an 
assessment of nutritional status and the exposure of the U.S. population to environmental 
chemicals and toxic substances.
All procedure were approved by the NCHS Research Ethics Review Board (Continuation of 
Protocol #2005-2006 http://www.cdc.gov/nchs/nhanes/irba98.htm), and all participants 
provided written informed consent. The unweighted response rate for participants aged 
20-39 years for NHANES 2007-2008 and NHANES 2009-2010 were 75.2% and 78.1%, 
respectively (http://www.cdc.gov/nchs/nhanes/response_rates_CPS.htm). For our analysis, 
we focused on young adult (ages 20-39 years) participants (n=3,785) in order to minimize 
conditions such as osteoporosis, which mobilizes cadmium and lead from the bone thus 
increasing their levels in the blood. Pregnant women were excluded. Of the participants who 
answered the Patient Health Questionnaire (PHQ)-9 module (n=3,316), we included only 
those participants who had measurements for blood lead and blood cadmium (n=3,169). 
Additionally, participants with missing information on a priori covariates were excluded 
from our analysis for a total sample size of 2,892 participants.
Outcome
The outcome was the presence or absence of depressive symptoms, as determined by score 
on the PHQ-9, a self-administered version of the depression module of the Primary Care 
Evaluation of Mental Disorders Questionnaire (PRIME-MD). PHQ-9 contains 9 questions 
that were used as a depression screener in NHANES 2007-2008 and 2009-2010. These are 
based on the 9 signs and symptoms for depression listed in the Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition (DSM-IV). Responses to these 9 questions were on 
a 4-point Likert scale of 0 to 3, indicating that the participant experienced the symptom “not 
at all,” “on several days,” “on more than half the days,” or “nearly every day” during the 
past 2 weeks for a total score ranging from 0 to 27. For our sample, the scores ranged from 
0-25, with a median value of 2, a 95th percentile of 13, and less than 10% having scores ≥ 
10. A prior validation study found that a score ≥10 achieved 88% sensitivity and 88% 
specificity for major depression (Kroenke et al. 2001). Therefore, a participant who scored 
10 or more was defined as having depressive symptoms. This cut-off has been validated for 
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the general population (Kocalevent et al. 2013) and has been applied in other NHANES 
studies (Golub et al.2010)
Covariates
Whole blood cadmium (BCd) and blood lead (BPb) concentrations were measured using 
inductively-coupled plasma mass spectrometry by CDC’s National Center for 
Environmental Health (NCEH), Division of Laboratory Sciences (DLS). Detailed 
methodology and QA/QC instructions are discussed in the NHANES Laboratory Procedures 
Manual (http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/
PbCd_E_met_lead_cadmium.pdf; http://www.cdc.gov/NCHS/data/nhanes/nhanes_09_10/
PbCd_F_met.pdf)
Blood cadmium was categorized by weighted quartile (Q) distribution. A total of 833 
participants had BCd values below the limit of detection (LOD 2007–2012: 0.20μg/l); 
therefore, these participants were considered the referent lowest cadmium quartile (BCdQ1). 
The cutpoints for the other BCd quartiles were as follows: BCdQ2 0.20-0.27μg/L; BCdQ3 
0.28-0.54 μg/L; and BCdQ4 >0.54 μg/L. Blood lead was categorized by weighted quartiles: 
BPbQ1 ≤ 0.63μg/dL; BPbQ2 0.64-0.90μg/dL; BPbQ3 0.91-1.36 μg/dL; BPbQ4 >1.36 μg/dL.
The regression models were adjusted for covariates that are associated with depression: age 
(categorized in weighted quartile), sex, race/ethnicity, education, poverty income ratio, 
obesity, alcohol consumption, smoking status, and blood lead. We obtained information 
about age (years), gender, race/ethnicity, and education from the household interview. Race/
ethnicity was categorized as non-Hispanic white, non-Hispanic black, Hispanic, and other. 
Poverty income ratio (PIR) is a measure of socioeconomic status and represents the 
calculated ratio of household income to the poverty threshold after accounting for inflation 
and family size. Body Mass Index (BMI) is calculated by the weight divided by height 
squared (kg/m2). The adult population was classified as overweight and obese with BMI 
measures of 25-29.9 and ≥30 kg/m2, respectively.
Alcohol consumption (amount consumed per week) and smoking information were obtained 
from the associated questionnaire. Cigarettes smoking was defined as non-smoker (smoke < 
100 cigarettes ever), former smoker (not currently smoking, but has smoked ≥100 cigarettes 
ever), and current smoker. Serum cotinine is a biomarker of secondhand smoke (SHS) and 
was categorized as: low exposed non-smoker (serum cotinine below detection limit); high 
exposed non-smokers (serum cotinine levels below or equal to 3.0 ng/mL); and exposed 
smokers (serum cotinine >3.0 ng/mL). The cutoff of 3.0 ng/mL to define active smoking 
was derived from Benowitz and colleagues (Benowitz et al.2009). Therefore, to avoid 
information bias due to self-reported cigarette smoking, we used both self-reported cigarette 
use and serum cotinine cutoff to define smoking status: smokers included self-reported 
current smokers and those with serum cotinine levels ≤ 3.0 ng/mL and non-smokers 
included self-reported former and never smokers and those with serum cotinine levels ≤ 3.0 
ng/mL. Former smokers were included with never smokers because the BCd levels were 
similar (geometric mean [GM] = 0.25μg/L and 0.22 μg/L, respectively), whereas current 
smokers had a higher BCd level (GM = 0.76 μg/L). Moreover, the use of SHS and self-
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reported smoking status as independent variables in the model did not change the association 
between cadmium and depressive symptoms.
Statistical Methods
MEC exam sample weights were used for analyses to account for the complex sampling 
design and non-response of NHANES. Weights for combined NHANES survey cycles were 
calculated according to NHANES guidelines (NCHS 2008b). We estimated sampling errors 
using the Taylor series linearized method. We used logistic regression to calculate adjusted 
odds. SAS 9.3 (SAS Institute, Cary, NC) was used for all statistical analyses and SAS-
Callable SUDAAN 10 (Research Triangle Institute, Research Triangle Park, NC) was used 
to account for the NHANES complex sample design. We also assessed possible interactions 
between cadmium and sex, but because the interaction was not statistically significant, it 
was not included in the models. P-values from Satterthwaite statistics were presented at the 
significance level < 0.05.
RESULTS
Table 1 presents the characteristics of the study population. The geometric mean age was 
similar in both men and women (data not shown). The geometric mean BCd level was 0.31 
μg/L. Blood cadmium geometric mean for women was (0.33 μg/L) and for men was (0.30 
μg/L) (data not shown). The number of individuals with depressive symptomswas 287 
(weighted percentage 7.85%). Table 2 shows the characteristics of depressive symptom 
cases and controls by covariates used in the models. Depressive symptoms were statistically 
significantly higher in women, in individuals with lower PIR, in those with less than high 
school education, in obese individuals, and in smokers. Additionally, depressive symptoms 
were significantly associated with s blood cadmium.
Logistic regression analysis adjusting for age, sex, race/ethnicity, education status, PIR, 
obesity, alcohol consumption, blood lead and smoking status showed that the highest BCd 
quartile was significantly associated with higher odds of having depressive symptoms (OR= 
2.79; 95% CI: 1.84, 4.25; p-value for trend = 0.001) compared to the referent lowest BCd 
quartile (Table 3). Analyses using continuous log natural-transformed cadmium confirmed 
the statistically significant association (data not shown).
Higher odds to have depressive symptoms was statistically significantly associated with 
current smoking status (OR = 1.54; 95% CI: 1.00, 2.36) compared to non-smokers, whereas 
blood lead levels were not statistically significantly associated (data not shown). Since 
cigarette smoking is related to cadmium exposure, we conducted a stratified analysis based 
on smoking status. We found that the highest quartile of BCd was statistically significantly 
associated with depressive symptoms both in non-smokers (OR = 2.91; 95% CI: 1.12, 7.58) 
and in current smokers (OR = 2.69; 95% CI: 1.13, 6.42) compared to the referent BCd 
quartile (Table 3).
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DISCUSSION
To our knowledge, this is the first study reporting an association of blood cadmium levels 
with depressive symptoms using a nationally representative sample.
Compared with persons with blood cadmium level less than 0.20 μg/L those with a level 
greater than 0.47 μg/L had a 2.8-fold increased risk of having depressive symptoms. 
Furthermore, after stratification by smoking status, the association of BCd with depressive 
symptoms persisted in both current smokers and non-smokers; therefore, the association of 
cadmium with depressive symptoms is not likely to be confounded by smoking or other 
compounds present in the cigarette smoking such as cotinine and lead.
Bouchard and colleagues (2009) previously reported an association between blood lead and 
major depression among young adult (20-39 years of age) participants in NHANES 
1999-2004. In our study using NHANES 2007-2010, BPb was not associated with 
depressive symptoms. Similarly, Golub and colleagues (2010) did not find an association 
between BPb and depression in adults aged 20 years and older participating in the NHANES 
2005-2006 cycle. These differences may be due to the decrease of blood lead that occurred 
in the last decades or to residual confounding.
There is a strong association between smoking and depression; however, this link may be 
bidirectional – depression increases the risks of smoking (Crone & Reijneveld 2007; Lerman 
et al. 1998; Pomerleau & Pomerleau 1992), and smoking increases the risks of depression 
(Aubin et al. 2012; Boden et al. 2010; Weaver & Etzel 2003). Studies conducted among 
non-smoking adults suggest that exposure to SHS is correlated with depression (Bandiera et 
al. 2010; Nakata et al. 2008); whereas, other studies fail to find such an association (Bot et 
al. 2013; Lam et al. 2013). In this study, among individuals not currently smoking, we did 
not find any association between serum cotinine and depressive symptoms (data not shown). 
However, there was an association between cadmium and depressive symptoms among 
those not currently smoking. This suggests that cadmium, whether from SHS or diet in non-
smokers, may be a contributing risk factor to depression.
The biological plausibility of our findings is unclear because of the scarcity of studies 
pertaining to cadmium exposure and neurobehavioral outcomes. Studies in rats have shown 
that cadmium can increase the permeability of the blood brain barrier, which can lead in the 
brain to intracellular cadmium accumulation and cell dysfunction in adult rats (Goncalves et 
al. 2010; Mendez-Armenta & Rios 2007). Impairment in the monoaminergic 
neurotransmission system is associated with the depression and anxiety disorder (Lanni et al. 
2009), and cadmium may contribute to the etiology of depression through perturbation of 
the catecholamine/serotonin system. Adult male rats exposed to cadmium show a decreased 
content of serotonine, dopamine and norepinephrine in all brain regions (Lafuente et al. 
2001, 2003). Other experimental studies on rats indicate that early exposure to cadmium can 
induce behavioral and neurotoxic effects, including a decrease of locomotor activity or an 
increase of anxiety-like behavior (Ali et al. 1990; Baranski 1984; Leret et al. 2003). 
Gonçalves and colleagues (2012) reported an impaired cognition and enhanced anxiety-like 
behavior associated with increased acetylcholinesterase activity and a decrease of Na+, K+-
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ATPase activity in pubertal male rats treated with cadmium in the diet. Studies of exposed 
children show that high cadmium concentrations in hair are associated with learning 
difficulties (Capel et al. 1981; Ciesielski et al 2012).
One of the strengths of the present study is the use of the structured self-report assessment 
PHQ-9, which is widely used in psychiatric research and has a high degree of 
correspondence with clinical interviews (Martin et al. 2006). The present study has several 
limitations, the most important being its cross-sectional design, which limits the inferences 
that can be made based on the findings. Medical conditions such as osteoporosis, during 
which cadmium and lead are released from the bone matrix to the blood may affect our 
findings. However, in this study few individuals were likely to have osteoporosis because of 
their young age (maximum age of 39 years). Blood cadmium is considered a biomarker for 
recent, short-term exposure; however, it was found that cadmium in blood is composed of a 
short half-life of 3-4 months (Jarup et al. 1983). The latter is reflective of the cadmium body 
burden; therefore, blood cadmium may be a good indication of long-term low-level exposure 
(Jarup et al. 1998). The depression status in our study is limited to answers in the PHQ-9 
about the experience of the participants during the past 2 weeks, so the so the presence of 
depressive symptoms reflect a current status. Therefore, blood cadmium (as a biomarker of 
recent exposure) may be appropriate to use in this case.
The association reported in this study could be biased by uncontrolled confounders such as 
genetic predisposition (Cohen-Woods et al. 2013). However, the models were adjusted for 
several likely important confounding factors (sex, age, race/ethnicity, education status, 
annual income, obesity, alcohol, smoking status, serum cotinine and blood lead). Although 
the possibility that depression leads to behavioral changes that increase exposure to 
cadmium (i.e. tobacco smoke) cannot be ruled out, the result among current nonsmokers 
may propose otherwise. Analyses that included only non-smokers indicate that residual 
confounding by smoking does not explain the associations of BCd levels and risks of 
depression, and that cadmium may be an independent risk factor of depression.
If cadmium exposure is associated with depression, continued efforts at reducing cadmium 
population exposures mainly through tobacco smoking cessation programs, which have the 
added benefit of decreased cadmium exposure through second- and third-hand smoke, may 
help decrease the population incidence of depression A recent meta-analysis reported that 
smoking cessation is associated with reduced depression (Taylor et al. 2014), findings that 
may help to overcome professional reluctance to intervene with smokers who have mental 
health problems (Chang et al. 2011; Johnson et al. 2010). Given that cadmium is associated 
with several chronic diseases (ATSDR 2012), the benefits of smoking cessation are 
multifold by decreasing both the incidence of smoking-related diseases as well as cadmium-
associated diseases
However, further studies, such as well-designed prospective studies to evaluate the effect of 
cadmium exposure and the risk of developing depression are needed to more fully 
understand the implications of the findings of this study.
Scinicariello and Buser Page 7
Psychol Med. Author manuscript; available in PMC 2016 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Acknowledgments
This research was supported in part by an appointment to the Research Participation Program at the Centers for 
Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through 
an interagency agreement between the U.S. Department of Energy and CDC (MCB).
Disclaimer: The findings and conclusion in this report are those of the author and do not necessarily represent the 
views of CDC/ATSDR.
References
Ali M, Mathur N, Chandra S. Effect of chronic cadmium exposure on locomotor behaviour of rats. 
Indian journal of experimental biology. 1990; 28:653. [PubMed: 2272652] 
ATSDR. Toxicological profile for cadmium. Atlanta, GA: US Agency for Toxic Substances and 
Disease Registry; 2012. 
Aubin HJ, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: A 
review. Neuroscience & Biobehavioral Reviews. 2012; 36:271–284. [PubMed: 21723317] 
Bandiera FC, Arheart KL, Caban-Martinez AJ, Fleming LE, McCollister K, Dietz NA, Leblanc WG, 
Davila EP, Lewis JE, Serdar B, Lee DJ. Secondhand smoke exposure and depressive symptoms. 
Psychosomatic medicine. 2010; 72:68–72. [PubMed: 19949159] 
Barański B. Behavioral alterations in offspring of female rats repeatedly exposed to cadmium oxide by 
inhalation. Toxicology letters. 1984; 22:53–61. [PubMed: 6464034] 
Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for 
distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United 
States between 1999 and 2004. American journal of epidemiology. 2009; 169:236–248. [PubMed: 
19019851] 
Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: tests of causal linkages 
using a longitudinal birth cohort. The British Journal of Psychiatry. 2010; 196:440–446. [PubMed: 
20513853] 
Bot M, Vink JM, Willemsen G, Smith JH, Neuteboom J, Kluft C, Boomsma DI, Penninx BW. 
Exposure to secondhand smoke and depression and anxiety: A report from two studies in the 
Netherlands. Journal of psychosomatic research. 2013; 75:431–436. [PubMed: 24182631] 
Bouchard MF, Bellinger DC, Weuve J, Matthews-Bellinger J, Gilman SE, Wright RO, Schwartz J, 
Weisskopf MG. Blood lead levels and major depressive disorder, panic disorder, and generalized 
anxiety disorder in US young adults. Archives of General Psychiatry. 2009; 66:1313–9. [PubMed: 
19996036] 
Capel ID, Pinnock MH, Dorrell H, Williams DC, Grant E. Comparison of concentrations of some 
trace, bulk, and toxic metals in the hair of normal and dyslexic children. Clinical Chemistry. 1981; 
27:879–881. [PubMed: 7237768] 
Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, Hotopf M, Stewart R. Life 
expectancy at birth for people with serious mental illness and other major disorders from a 
secondary mental health care case register in London. PloS one. 2011; 6:e19590. [PubMed: 
21611123] 
Ciesielski T, Weuve J, Bellinger DC, Schwartz J, Lanphear B, Wright RO. Cadmium exposure and 
neurodevelopmental outcomes in US children. Environmental health perspectives. 2012; 120:758–
63. [PubMed: 22289429] 
Cohen-Woods S, Craig IW, McGuffin P. The current state of play on the molecular genetics of 
depression. Psychological Medicine. 2013; 43:673–87. [PubMed: 22687339] 
Crone MR, Reijneveld SA. The association of behavioural and emotional problems with tobacco use in 
adolescence. Addictive behaviors. 2007; 32:1692–1698. [PubMed: 17175113] 
Golub NI, Winters PC, van Wijngaarden E. A population-based study of blood lead levels in relation 
to depression in the United States. International Archives of Occupational and Environmental 
Health. 2010; 83:771–7. [PubMed: 19967393] 
Goncalves JF, Fiorenza AM, Spanevello RM, Mazzanti CM, Bochi GV, Antes FG, Stefanello N, 
Rubin MA, Dressler VL, Morsch VM, Schetinger MR. N-acetylcysteine prevents memory deficits, 
Scinicariello and Buser Page 8
Psychol Med. Author manuscript; available in PMC 2016 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium. 
Chemico-biological Interaction. 2010; 186:53–60.
Goncalves JF, Nicoloso FT, da Costa P, Farias JG, Carvalho FB, da Rosa MM, Gutierres JM, Abdalla 
FH, Pereira JS, Dias GR, Barbosa NB, Dressler VL, Rubin MA, Morsch VM, Schetinger MR. 
Behavior and brain enzymatic changes after long-term intoxication with cadmium salt or 
contaminated potatoes. Food & Chemical Toxicology. 2012; 50:3709–18. [PubMed: 22819775] 
Hart RP, Rose CS, Hamer RM. Neuropsychological effects of occupational exposure to cadmium. 
Journal of clinical and experimental neuropsychology. 1989; 11:933–943. [PubMed: 2592532] 
Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure--a 
review of the literature and a risk estimate. Scandinavian journal of work, environment & health. 
1998; 24(Suppl 1):1–51.
Jarup L, Rogenfelt A, Elinder CG, Nogawa K, Kjellstrom T. Biological half-time of cadmium in the 
blood of workers after cessation of exposure. Scandinavian journal of work, environment & health. 
1983; 9:327–31.
Johnson JL, Moffat BM, Malchy LA. In the shadow of a new smoke free policy: A discourse analysis 
of health care providers’ engagement in tobacco control in community mental health. International 
Journal of Mental Health Systems. 2010; 4:23. [PubMed: 20667105] 
Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annual review of public 
health. 2013; 34:119–138.
Kocalevent RD, Hinz A, Brahler E. Standardization of the depression screener Patient Health 
Questionnaire (PHQ-9) in the general population. General Hospital Psychiatry. 2013; 35:551–555. 
[PubMed: 23664569] 
Kroenke K, Spitzer RL, Williams JB. The PHQ-9. Journal of general internal medicine. 2001; 16:606–
613. [PubMed: 11556941] 
Lafuente A, Gonzalez-Carracedo A, Romero A, Esquifino A. Effect of cadmium on 24-h variations in 
hypothalamic dopamine and serotonin metabolism in adult male rats. Experimental brain research. 
2003; 149:200–206. [PubMed: 12610688] 
Lafuente A, Márquez N, Perez-Lorenzo M, Pazo D, Esquifino AI. Cadmium effects on hypothalamic-
pituitary-testicular axis in male rats. Experimental Biology and Medicine. 2001; 226:605–611. 
[PubMed: 11395933] 
Lam E, Kvaavik E, Hamer M, Batty GD. Association of secondhand smoke exposure with mental 
health in men and women: cross-sectional and prospective analyses using the U.K. Health and 
Lifestyle Survey. European psychiatry: the journal of the Association of European Psychiatrists. 
2013; 28:276–281. [PubMed: 22959598] 
Lanni C, Govoni S, Lucchelli A, Boselli C. Depression and antidepressants: molecular and cellular 
aspects. Cellular and molecular life sciences. 2009; 66:2985–3008. [PubMed: 19521663] 
Leret ML, Millan JA, Antonio MT. Perinatal exposure to lead and cadmium affects anxiety-like 
behaviour. Toxicology. 2003; 186:125–30. [PubMed: 12604176] 
Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG. Depression and self-
medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health 
Psychology. 1998; 17:56. [PubMed: 9459071] 
Martin A, Rief W, Klaiberg A, Braehler E. Validity of the brief patient health questionnaire mood 
scale (PHQ-9) in the general population. General hospital psychiatry. 2006; 28:71–77. [PubMed: 
16377369] 
Mendez-Armenta M, Rios C. Cadmium neurotoxicity. Environ Toxicol Pharmacol. 2007; 23:350–8. 
[PubMed: 21783780] 
Nakata A, Takahashi M, Ikeda T, Hojou M, Nigam JA, Swanson NG. Active and passive smoking and 
depression among Japanese workers. Preventive medicine. 2008; 46:451–456. [PubMed: 
18314186] 
National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey 
Home Page. Centers for Disease Control and Prevention, National Center for Health Statistics; 
Atlanta, GA: 2008a. http://www.cdc.gov/nchs/nhanes.htm.2008 [April 2014]
National Center for Health Statistics (NCHS). Constructing Weights for Combined NHANES Survey 
Cycles. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Health 
Scinicariello and Buser Page 9
Psychol Med. Author manuscript; available in PMC 2016 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Statistics; 2008b. Continuous National Health and Nutrition Examination Survey (NHANES) Web 
Tutorial. http://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/Weighting/intro.htm [April 
2014]
Pomerleau CS, Pomerleau OF. Euphoriant effects of nicotine in smokers. Psychopharmacology. 1992; 
108:460–465. [PubMed: 1410160] 
Rodgman, A.; Perfetti, TA. The Chemical Components of Tobacco and Tobacco Smoke. CRC Press, 
Taylor & Francis Group; 2008. 
Stanley PC, Wakwe VC. Toxic trace metals in the mentally ill patients. The Nigerian Postgraduate 
Medical Journal. 2002; 9:199–204. [PubMed: 12690679] 
Stellern J, Marlowe M, Cossairt A, Errera J. Low lead and cadmium levels and childhood visual-
perception development. Perceptual and motor skills. 1983; 56:539–544. [PubMed: 6866662] 
Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US 
workers with depression. JAMA: the journal of the American Medical Association. 2003; 
289:3135–3144. [PubMed: 12813119] 
Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health 
after smoking cessation: systematic review and meta-analysis. BMJ. 2014; 348:g1151. [PubMed: 
24524926] 
Viaene M, Masschelein R, Leenders J, De Groof M, Swerts L, Roels H. Neurobehavioural effects of 
occupational exposure to cadmium: a cross sectional epidemiological study. Occupational and 
environmental medicine. 2000; 57:19–27. [PubMed: 10711265] 
Weaver TL, Etzel JC. Smoking patterns, symptoms of PTSD and depression: preliminary findings 
from a sample of severely battered women. Addictive behaviors. 2003; 28:1665–1679. [PubMed: 
14656552] 
Scinicariello and Buser Page 10
Psychol Med. Author manuscript; available in PMC 2016 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Scinicariello and Buser Page 11
TABLE 1
Sample size (N) and weighted characteristics of young adults participants in NHANES 2007-2010
ALL
N Weighted
Blood Cadmium (μg/L), GM (SE) 2892 0.31 (0.01)
Blood Lead (μg/dL), GM (SE) 2892 0.96 (0.02)
Age (Years), GM (SE) 2892 28.93 (0.34)
BMI(kg/m2), GM (SE) 2892 27.32 (0.18)
Serum Cotinine (ng/mL), GM (SE) 2892 0.75 (0.11)
Sex
Men, % (SE) 1439 51.38 (1.05)
Women, % (SE) 1453 48.62 (1.05)
Depressive Symptoms
Yes, % (SE) 287 7.85 (0.44)
No, % (SE) 2605 92.15 (0.44)
Body Weight
Underweight/Normal weight, % (SE) 1044 38.18 (1.58)
Overweight, % (SE) 861 29.89 (0.89)
Obese, % (SE) 987 31.93 (1.45)
Poverty Income Ratio
PIR (below or equal poverty line), % (SE) 794 19.84 (1.18)
PIR (above poverty line), % (SE) 2098 80.16 (1.18)
Smoking Status
Current Smokers (self-report and LBXCOT>3.00 ng/mL), % (SE) 1093 37.15 (1.52)
Not-Current Smoker (Self-report Former and never smoker and lbxcot≥3ng/mL), % (SE) 1799 62.85 (1.52)
Alcohol Consumption
No Alcohol, % (SE) 615 18.31 (0.95)
1-4 drinks per week, % (SE) 1826 66.70 (1.51)
>4 drinks per week, % (SE) 451 14.99 (1.11)
Education Level
Less than High School, % (SE) 670 17.37 (1.14)
Completed High School, % (SE) 689 21.89 (1.18)
More than High School, % (SE) 1533 60.74 (1.90)
Race/ethnicity
White (Non-Hispanic), % (SE) 1306 63.24 (2.92)
Non-Hispanic Black, % (SE) 527 11.59 (1.19)
Hispanic, % (SE) 896 18.12(2.21)
Other, % (SE) 163 7.05 (0.82)
Blood Cadmium Quartile
BCd Q1 (Below limit of detection 0.20 μg/L), % (SE) 833 31.44 (1.12)
BCd Q2 (0.20 – 0.27 μg/L), % (SE) 640 22.19 (0.92)
BCd Q3 (0.28 – 0.54 μg/L), % (SE) 719 23.74 (0.97)
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ALL
N Weighted
BCd Q4 (>0.54 μg/L), % (SE) 700 22.63 (1.36)
Blood Lead Quartile
BPb Q1 (≤ 0.63 μg/dL), % (SE) 661 24.75 (1.16)
BPb Q2 (0.64 – 0.90 μg/dL), % (SE) 734 25.39 (1.23)
BPb Q3 (0.91 – 1.36 μg/dL), % (SE) 712 25.00 (0.86)
BPb Q4 (>01.36 μg/dL), % (SE) 785 24.86 (1.30)
Age Quartile
Age Q1 (20 - 24 years), % (SE) 743 25.55 (1.40)
Age Q2 (25 – 29 years), % (SE) 669 25.78 (1.28)
Age Q3 (30 – 34 years), % (SE) 717 22.54 (0.88)
Age Q4 (35 – 39 years), % (SE) 763 26.13 (0.89)
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TABLE 2
Chi Square analyses between depressive symptoms cases and controls in young adults (aged 20-39 years) in 
NHANES 2007-2010.
Depressive symptoms
χ2 p valueCase, n Control, n
Sex
Men 94 1345 <.001
Women 193 1260
Race/Ethnicity
Non-Hispanic White 119 1187
Non-Hispanic Black 62 465 .04
Hispanic 95 801
Other 11 152
Age quartile
AgeQ1 (20 - 24 years) 68 675
AgeQ2 (25 – 29 years) 58 611
AgeQ3 (30 – 34 years) 68 649 .09
AgeQ4 (35 – 39 years) 93 670
Education level
Less than High School 102 568
Completed High School 71 618 .002
More than High School 114 1419
Poverty Income Ratio
PIR≤1 131 663 <.001
PIR > 1 156 1942
OBESITY
Underweight/Normal 88 956
Overweight 74 787 .002
Obese 125 862
Alcohol consumption
No Alcohol 64 551
1-4 drinks per week 172 1654 .46
>4 drinks per week 51 400
Smoking Status
Current Smokers (self-report and LBXCOT>3.00 ng/mL) 163 930
Not-Current Smoker (Self-report Former and never smoker and lbxcot≥3ng/mL 124 1675 <.001
Blood Cadmium Quartile
BCd Q1 (Below limit of detection 0.20 μg/L) 53 780
BCd Q2 (0.20 – 0.27 μg/L) 44 596 <.001
BCd Q3 (0.28 – 0.54 μg/L) 61 658
BCd Q4 (>0.54 μg/L) 129 571
Blood Lead Quartile
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Depressive symptoms
χ2 p valueCase, n Control, n
BPb Q1 (≤ 0.63 μg/dL) 66 595
BPb Q2 (0.64 – 0.90 μg/dL) 76 658 .96
BPb Q3 (0.91 – 1.36 μg/dL) 76 636
BPb Q4 (>01.36 μg/dL) 69 716
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Table 3
Adjusted* ORs (95% CIs) of depressive symptoms by blood cadmium levels in young adults (aged 20-39 
years) in NHANES 2007-2010
All Participants * Non-smokers* Current Smokers*
Cadmium
BCd Q1 (Below limit of detection 0.20 μg/L) 1.00 1.00 1.00
BCd Q2 (0.20 – 0.27 μg/L), 1.04 (0.58, 1.87) 1.28 (0.65, 2.55) 0.63 (0.27, 1.45)
BCd Q3 (0.28 – 0.54 μg/L), 1.11 (0.70, 1.76) 1.26 (0.71, 2.25) 1.02 (0.36, 2.94)
BCd Q4 (>0.54 μg/L) 2.79 (1.84, 4.25) 2.91 (1.12, 7.58) 2.69 (1.13, 6.42)
 p trend 0.001 0.28 <0.001
*Adjusted for age, sex, race/ethnicity, education, PIR, obesity, alcohol intake, blood lead, and smoking status (defined as current smoker: self-
report and LBXCOT>3.00 ng/mL; and non-smoker: Self-report Former and never smoker and lbxcot≥3ng/mL)
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